NUIX LIMITED (NXL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NXL - NUIX LIMITED

FNArena Sector : Software & Services

Year End: June

GICS Industry Group : NONE

Debt/EBITDA: 0.15

Index: ASX200 | ASX300 | ALL-ORDS | ALL-TECH

Nuix is an Australian technology company providing investigative analytics and intelligence software for transforming large amounts of data into actionable intelligence. The company listed in December 2020.

LAST PRICE	CHANGE +/-	CHANGE %	VOLUME
$2.05 09 Jul 2025	0.010 OPEN $2.04	0.49% HIGH $2.07	806,496 LOW $2.00

LAST PRICE

CHANGE +/-

CHANGE %

VOLUME

$2.05

09 Jul
2025

0.010

OPEN

$2.04

0.49%

HIGH

$2.07

806,496

LOW

$2.00

TARGET

$5.70

178.0% upside

OTHER COMPANIES IN THE SAME SECTOR
360 . AHI . ALC . AMX . ATA . BMT . COS . DOC . EVS . GTK . KYP . NET . QOR . RDY . SKO . UBN . VGL . XF1 . YOJ .

FNARENA'S MARKET CONSENSUS FORECASTS

Title	FY23 Actual	FY24 Actual	FY25 Forecast	FY26 Forecast
EPS (cps)	xxx	1.6	2.8	xxx
DPS (cps)	xxx	0.0	0.0	xxx
EPS Growth	xxx	N/A	80.6%	xxx
DPS Growth	xxx	N/A	N/A	xxx
PE Ratio	xxx	N/A	74.6	xxx
Dividend Yield	xxx	N/A	0.0%	xxx
Div Pay Ratio(%)	xxx	N/A	N/A	xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

HISTORICAL DATA ARE ALL IN AUD

Copyright © 2025 FactSet UK Limited. All rights reserved

Title	2019	2020	2021	2022	2023	2024
EPS Basic	xxx	xxx	xxx	xxx	xxx	1.6
DPS All	xxx	xxx	xxx	xxx	xxx	0.0
Sales/Revenue	xxx	xxx	xxx	xxx	xxx	220.6 M
Book Value Per Share	xxx	xxx	xxx	xxx	xxx	88.6
Net Operating Cash Flow	xxx	xxx	xxx	xxx	xxx	50.3 M
Net Profit Margin	xxx	xxx	xxx	xxx	xxx	2.28 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title	2019	2020	2021	2022	2023	2024
Return on Capital Employed	xxx	xxx	xxx	xxx	xxx	1.80 %
Return on Invested Capital	xxx	xxx	xxx	xxx	xxx	1.76 %
Return on Assets	xxx	xxx	xxx	xxx	xxx	1.16 %
Return on Equity	xxx	xxx	xxx	xxx	xxx	1.80 %
Return on Total Capital	xxx	xxx	xxx	xxx	xxx	5.85 %
Free Cash Flow ex dividends	xxx	xxx	xxx	xxx	xxx	49.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title	2019	2020	2021	2022	2023	2024
Short-Term Debt	xxx	xxx	xxx	xxx	xxx	3 M
Long Term Debt	xxx	xxx	xxx	xxx	xxx	7 M
Total Debt	xxx	xxx	xxx	xxx	xxx	10 M
Goodwill - Gross	xxx	xxx	xxx	xxx	xxx	22 M
Cash & Equivalents - Generic	xxx	xxx	xxx	xxx	xxx	38 M
Price To Book Value	xxx	xxx	xxx	xxx	xxx	3.48

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title	2019	2020	2021	2022	2023	2024
Capex	xxx	xxx	xxx	xxx	xxx	33.1 M
Capex % of Sales	xxx	xxx	xxx	xxx	xxx	15.00 %
Cost of Goods Sold	xxx	xxx	xxx	xxx	xxx	71 M
Selling, General & Admin. Exp & Other	xxx	xxx	xxx	xxx	xxx	132 M
Research & Development	xxx	xxx	xxx	xxx	xxx	19 M
Investments - Total	xxx	xxx	xxx	xxx	xxx	0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
EXTRA COVERAGE

EXPERT VIEWS

Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Shaw and Partners	25/02/2025	1	Buy, High Risk	$5.70	178.05%	Nuix reported first-half FY25 results in line with Shaw and Partners' expectations, with management reaffirming full-year guidance and signalling a strong second half. The company continues its transition towards a subscription-based model, driving higher recurring revenue and improved cash flow stability, explains the broker. Management remains confident in its growth strategy, observes Shaw, with key pipeline opportunities in legal, regulatory, and corporate compliance markets. The analysts see significant upside potential as Nuix executes its strategic initiatives and scales its recurring revenue base. The Buy, High Risk rating and $5.70 target are maintained. FORECAST Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of 2.80 cents. Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 10.00 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Shaw and Partners

25/02/2025

Buy, High Risk

$5.70

178.05%

Nuix reported first-half FY25 results in line with Shaw and Partners' expectations, with management reaffirming full-year guidance and signalling a strong second half.

The company continues its transition towards a subscription-based model, driving higher recurring revenue and improved cash flow stability, explains the broker.

Management remains confident in its growth strategy, observes Shaw, with key pipeline opportunities in legal, regulatory, and corporate compliance markets.

The analysts see significant upside potential as Nuix executes its strategic initiatives and scales its recurring revenue base.

The Buy, High Risk rating and $5.70 target are maintained.

FORECAST
Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of 2.80 cents.
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 10.00 cents.

Access Stockbroker Research History >

EXTRA COVERAGE

Display All Commentary

No. Of Recommendations

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Moelis	xx/xx/xxxx	3	xxxx	$xx.xx	xx.xx%	Broker commentary and detailed analysis is available for Full Members Only. Login above or Get a Free Trial
Petra Capital	30/01/2025	1	Buy	$4.87	137.56%	Nuix reiterated its guidance for annual contract value (ACV) growth of 15% for FY25 but included a range of 11-16%. Petra Capital expects 1H25 result to demonstrate modest ACV growth of 8-9% and has lowered its FY25 growth estimate to 10.9% to be the lower end of the company's 11-16% range. The broker's EBITDA forecasts fall on lower top-line revenue, lower gross profit and higher R&D expense versus capitalised. These detractors are offset by lower sales and distribution expenses, reflecting a more subdued sales environment. On the positive side, the broker notes NEO sales run rate of 46 deals is running ahead of its estimate of 48 for FY25 but will make compositional ACV adjustments to its forecasts at the 1H25 result. Target price cut to $4.87 from $7.20. Buy rating retained. FORECAST Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -0.50 cents. Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of 4.70 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Moelis

xx/xx/xxxx

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Petra Capital

30/01/2025

Buy

$4.87

137.56%

Nuix reiterated its guidance for annual contract value (ACV) growth of 15% for FY25 but included a range of 11-16%.

Petra Capital expects 1H25 result to demonstrate modest ACV growth of 8-9% and has lowered its FY25 growth estimate to 10.9% to be the lower end of the company's 11-16% range.

The broker's EBITDA forecasts fall on lower top-line revenue, lower gross profit and higher R&D expense versus capitalised. These detractors are offset by lower sales and distribution expenses, reflecting a more subdued sales environment.

On the positive side, the broker notes NEO sales run rate of 46 deals is running ahead of its estimate of 48 for FY25 but will make compositional ACV adjustments to its forecasts at the 1H25 result.

Target price cut to $4.87 from $7.20. Buy rating retained.

FORECAST
Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -0.50 cents.
Petra Capital forecasts a full year FY26 dividend of 0.00 cents and EPS of 4.70 cents.

Access Extra Coverage Research History >

NXL STOCK CHART

FNArena News on NXL

1	Australian Broker Call Extra Edition – May 12, 2025 May 12 2025 - Daily Market Reports

2	Next Week At A Glance – 14-17 Apr 2025 Apr 11 2025 - Weekly Reports

3	Australian Broker Call Extra Edition – Apr 09, 2025 Apr 09 2025 - Daily Market Reports

4	In Case You Missed It – BC Extra Upgrades & Downgrades – 07-03-25 Mar 07 2025 - Weekly Reports

5	Australian Broker Call Extra Edition – Mar 03, 2025 Mar 03 2025 - Daily Market Reports

Latest Software & Services News

1	ikeGPS Positioned For Multi-Decade Tailwinds Jul 08 2025 - Small Caps

2	Xero’s Bold US Play Jun 27 2025 - Australia

3	Australia’s Digital Infrastructure Opportunity Jun 23 2025 - Australia

4	FNArena Visits NextDC’s S3 Data Centre Jun 19 2025 - Feature Stories

5	Rudi’s View: Macquarie Technology (Stock In Focus) Jun 18 2025 - Rudi's View

6	WiseTech’s Big Bold Bet On E2open May 29 2025 - Australia

7	Rudi’s View: How Do We Value The Future? May 28 2025 - Rudi's View

8	TechnologyOne: The ‘Beat’ Goes On May 23 2025 - Australia

9	AI Investments Fuel Australia’s Data Centre Future May 22 2025 - Feature Stories

10	Gentrack Stumbles, But Confidence Remains High May 21 2025 - Small Caps

Dividend Yield Today On Last Actual Payout :	0.00
Estimated Dividend Growth (Average Of Past Three Years)	%
Amount Invested	$
Tell Me The Dividend After This Many Years

	Yield	Yield on investment
This Year
Year 1
Year 2
Year 3
Year 4
Year

1	Australian Broker Call Extra Edition – May 12, 2025 May 12 2025 - Daily Market Reports

2	Next Week At A Glance – 14-17 Apr 2025 Apr 11 2025 - Weekly Reports

3	Australian Broker Call Extra Edition – Apr 09, 2025 Apr 09 2025 - Daily Market Reports

4	In Case You Missed It – BC Extra Upgrades & Downgrades – 07-03-25 Mar 07 2025 - Weekly Reports

5	Australian Broker Call Extra Edition – Mar 03, 2025 Mar 03 2025 - Daily Market Reports

Get 2 Weeks free trial

Sign Up

Member Login

NUIX LIMITED (NXL)
Share Price Analysis and Chart